Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Taxane”

443 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 443 results

Testing effectiveness (Phase 2)Study completedNCT00044538
What this trial is testing

Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 102
Not applicableStudy completedNCT04659980
What this trial is testing

Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 62
Testing effectiveness (Phase 2)UnknownNCT03562390
What this trial is testing

Irinotecan for Advanced and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Liaoning Cancer Hospital & Institute 124
Testing effectiveness (Phase 2)Study completedNCT02834403
What this trial is testing

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Who this might be right for
Metastatic Triple Negative Breast Cancer
The Methodist Hospital Research Institute 37
Large-scale testing (Phase 3)Active Not RecruitingNCT04784715
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Who this might be right for
Breast Cancer; HER2-positive; Metastatic
AstraZeneca 1,157
Testing effectiveness (Phase 2)UnknownNCT01270373
What this trial is testing

NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After?

Who this might be right for
Breast Cancer
Instituto Nacional de Cancer, Brazil 112
Testing effectiveness (Phase 2)Looking for participantsNCT07109817
What this trial is testing

Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

Who this might be right for
Breast CancerPeripheral Neuropathy
Montefiore Medical Center 116
Testing effectiveness (Phase 2)Ended earlyNCT01815346
What this trial is testing

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 4
Not applicableUnknownNCT02506361
What this trial is testing

Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 800
Large-scale testing (Phase 3)Study completedNCT00112294
What this trial is testing

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Eli Lilly and Company 755
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Post-approval studies (Phase 4)UnknownNCT00912639
What this trial is testing

A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer

Who this might be right for
Recurrent Breast Cancer
Korean Breast Cancer Study Group 90
Testing effectiveness (Phase 2)Study completedNCT00080262
What this trial is testing

Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

Who this might be right for
Breast CancerMetastases
R-Pharm 125
Not applicableStudy completedNCT04256512
What this trial is testing

Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients

Who this might be right for
Breast Carcinoma
Mayo Clinic 94
Early research (Phase 1)Looking for participantsNCT07178171
What this trial is testing

QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
Xijing Hospital 30
Not applicableStudy completedNCT01276899
What this trial is testing

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Jewish General Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01438307
What this trial is testing

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Stage IV NSCLCMetastatic NSCLC
University of Alabama at Birmingham 28
Not applicableEnded earlyNCT03619044
What this trial is testing

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.

Who this might be right for
HER2-positive Breast Cancer
Institut Claudius Regaud 4
Testing effectiveness (Phase 2)UnknownNCT02829008
What this trial is testing

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Chinese Academy of Medical Sciences 120
Testing effectiveness (Phase 2)Study completedNCT00394810
What this trial is testing

Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
CASI pharmaceuticals, Inc. 21
Load More Results